Fineotex Chemical working capital

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
77.28×77.28×63.83×50.96×57.50×
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
95.99×95.99×87.15×77.05×74.94×
76.79×76.79×72.17×62.87×57.10×
96.48×96.48×78.81×65.14×75.34×
2.79×2.13×2.86×3.01×3.34×
0.78×0.78×0.78×1.17×1.36×
−0.19×−0.19×0.63×0.80×1.21×
−0.18×−0.18×0.54×0.66×0.96×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

FCL₹51.19

Fineotex Chemical Limited

· Chemicals
₹ CrorePeersEPIGRALYASHOGUJALKALIFOSECOINDVISHNUGALAXYSURFTATVAJUBLCPLMcap ₹5,961 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)57.5050.9663.8377.2877.28
Receivable Days (DSO)74.9477.0587.1595.9995.99
Payable Days (DPO)57.1062.8772.1776.7976.79
Cash Conversion Cycle (days)75.3465.1478.8196.4896.48
Working Capital Turnover3.343.012.862.132.79
Asset Turnover1.361.170.780.780.78
Cash Conversion (CFO/Net Income)1.210.800.63-0.19-0.19
CFO/EBITDA0.960.660.54-0.18-0.18
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.